District Court, S.D. New York November 2, 2015, No. 14 Civ. 1650(KBF) (Regeneron Pharmaceuticals, Inc. v. Merus B.V.)

OPINION & ORDER

KATHERINE B. FORREST, District Judge:

On March 11, 2014, Regeneron filed twin patent infringement actions: one against Merus B.V. (“Merus”), a company based in the Netherlands, and another against Ablexis LLC (“Ablexis”). (See ECF No. 1.) In short complaints, each consisting of a few substantive paragraphs, Regeneron accused both companies of infringing U.S. Patent No.